Medication info

HyuRions Injection 200 IU/mL (Sodium Heparin)

Prescription medicationInjections
Ingredient · strength
Heparin Sodium›Strength being verified
Manufacturer / importer
Huons Co., Ltd.
Appearance
A clear liquid that is colorless to pale yellow contained in a plastic vial
Packaging
20 milliliters/ampoule[* 50]
Approval status
Active

MFDS item code 202004282 · Approved 2020.06.08 · Insurance code 670608611

Summary

Main use
Prevention of blood coagulation during use of an extracorporeal circulation device for hemodialysis
Who uses it
Adults
Adult dosage
This drug is generally administered according to the following dosing regimen; however, the dose should be determined according to the case (e.g., symptoms), site of application, and purpose. Usually, adjust the dose according to age and symptoms so that, after administration of this drug, the whole-blood clotting time (Lee-White method) or whole-blood activated partial thromboplastin time (WBAPTT) is 2~3 times the normal value. Use during extracorporeal circulation (hemodialysis) For artificial kidney treatment, the appropriate dose for each patient is calculated before dialysis based on the results of an individual heparin sensitivity test. With systemic heparinization, 1,000~5,000 units are usually administered before the start of dialysis, followed after dialysis begins by continuous administration of 500~1,500 units per hour or intermittent additional doses of 500~1,500 units every hour. With regional heparinization, infuse 1,500~2,500 units per hour continuously and neutralize with protamine sulfate during extracorporeal circulation.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Prevention of blood coagulation during use of an extracorporeal circulation device for hemodialysis

  • Blood clotting
View approved original text

This medication is used to prevent blood clotting when using an extracorporeal circulation device during blood dialysis. It helps maintain smooth circulation of blood outside the body, enhancing therapeutic effects and reducing the risk of complications during dialysis. Thus, it plays an essential role in safe and effective blood dialysis treatment.

Dosage and Administration

Adult dosage

This drug is generally administered according to the following dosing regimen; however, the dose should be determined according to the case (e.g., symptoms), site of application, and purpose. Usually, adjust the dose according to age and symptoms so that, after administration of this drug, the whole-blood clotting time (Lee-White method) or whole-blood activated partial thromboplastin time (WBAPTT) is 2~3 times the normal value. Use during extracorporeal circulation (hemodialysis) For artificial kidney treatment, the appropriate dose for each patient is calculated before dialysis based on the results of an individual heparin sensitivity test. With systemic heparinization, 1,000~5,000 units are usually administered before the start of dialysis, followed after dialysis begins by continuous administration of 500~1,500 units per hour or intermittent additional doses of 500~1,500 units every hour. With regional heparinization, infuse 1,500~2,500 units per hour continuously and neutralize with protamine sulfate during extracorporeal circulation.

Precautions

This medication is a very potent drug and must be used only under the strict supervision of a physician. Special precautions should be taken when administering to patients with diseases that have a high risk of bleeding, as bleeding can occur in various parts of the body in those receiving this medication. It should not be administered to patients who have hypersensitivity to this drug, those with inappropriate results from blood coagulation tests, patients with existing bleeding issues, severe liver or kidney disease, etc. Caution is also required for patients who have recently undergone surgery or trauma, or those who have received spinal or epidural anesthesia. During use, blood coagulation ability tests and platelet counts should be checked regularly to detect and respond to side effects such as bleeding or thrombocytopenia early. If severe thrombocytopenia occurs, administration should be stopped immediately, and alternative anticoagulants should be used if necessary. This medication may interact with various drugs; extra caution is needed when used in conjunction with pain relievers, anti-inflammatory drugs, and anticoagulants. Women who are pregnant or may become pregnant should be particularly cautious due to the risk of uterine and placental bleeding, and careful management is required during delivery. Elderly patients and children may have an increased risk of bleeding, requiring extra caution during administration. In the case of overdose, hemorrhagic complications may arise; therefore, neutralization with protamine sulfate may be needed, keeping in mind the possible occurrence of adverse reactions throughout this process. To prevent infection during administration, the patient's skin and the instruments used should be thoroughly disinfected, and intramuscular injections are best avoided. This medication should be used immediately after opening, and any remaining solution should be discarded.

Side effects

  • Hemorrhage
  • fatal hemorrhage
  • acute adrenal insufficiency
  • adrenal hemorrhage
  • ovarian hemorrhage
  • retroperitoneal hemorrhage
  • gastrointestinal hemorrhage
  • cerebral hemorrhage
  • thrombocytopenia
  • arterial and venous thrombosis
Show 42 more
  • acute reversible thrombocytopathy
  • elevated γ-GTP
  • elevated LDH
  • elevated AST
  • elevated ALT
  • pruritus
  • urticaria
  • chills
  • fever
  • rhinitis
  • bronchial asthma
  • tearing
  • conjunctivitis
  • cyanosis
  • tachycardia
  • pressure sensation
  • angioedema
  • nausea
  • vomiting
  • hypotension
  • dyspnea
  • bronchospasm
  • shock
  • alopecia
  • vitiligo
  • hemorrhagic necrosis
  • hypoaldosteronism
  • osteoporosis
  • rebound effect
  • dyslipidemia
  • renal function suppression
  • localized painful hematoma
  • priapism
  • diabetes mellitus
  • hyperkalemia
  • hyperalkalaminemia
  • metabolic acidosis
  • elevated lipase
  • vascular spasm response
  • erythema
  • mild pain
  • ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is safe to keep it at room temperature between 1 and 30 degrees Celsius. Keeping it stored this way preserves the medication's effectiveness.

Appearance and packaging

Appearance

A clear liquid that is colorless to pale yellow contained in a plastic vial

Package unit

20 milliliters/ampoule[* 50]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.